EU – Medicinal products and medical devices: Coordinated approach in case of a withdrawal of the United Kingdom from the Union without a deal
Published in Brexit and European Commission
More from BrexitMore posts in Brexit »
- UK – Medicines and Medical Devices Bill: overarching documents
- Ireland – HPRA update – Brexit Transitional Period: Implications for Medicine and Medical Device Companies up to 31 December 2020
- From RAPS – UK Introduces Medicines, Medical Devices Bill in Post-Brexit Overhaul
- UK – Future of UK Life Sciences: how to reshape the industry for the 2020s (from The Economist)
- Update from GOV.UK – Regulating medical devices in the event of a no-deal Brexit – UK Responsible Person
More from European CommissionMore posts in European Commission »
- EU – Guidance – Clinical evaluation assessment report template
- EU – Team NB position statement on the requirements for the EU MDR/IVDR Notified Body Partners under the Technical Cooperation Program on Exchange of Medical Device Quality Management System Regulation and ISO 13485 Audit Reports (TCP III)
- UK – MHRA – Medical Device “Certificates of Compliance” / “Attestation of Conformity” have no legal standing under MDR
- EU – Availability and capacity of notified bodies to carry out conformity assessments for COVID-19 related medical devices and in vitro diagnostic medical devices
- EU – New relocated website for medical devices in the EU Commission website
Be First to Comment